Privacy/HIPAA Transactions Sample Clauses

Privacy/HIPAA Transactions. Qualifications: • Applicant is a covered entity and complies with the regulations issued pursuant to the Health Insurance Portability and Accountability Act (HIPAA) at 45 CFR parts 160 and 164, subparts A and E [the Privacy Rule] as it applies to health plans. (NOTE: In applying the definition of “marketing” under the Privacy Rule, Applicant’s information and outreach efforts under the drug card program that are directly related to covered drugs and non-prescription drugs for which the Applicant will offer a discount, including information on drug interactions, are permitted uses of protected health information as health care operations.) • Applicant complies with the Privacy Rule as it applies to business associates of CMS for the purposes of operating the transitional assistance portion of the drug card program. • Applicant notifies each beneficiary, prior to enrollment or at the time of enrollment, of expected uses and disclosures of the beneficiary’s protected health information, as well as the beneficiary’s rights and Applicant’s duties with respect to such information. Such notice is provided in plain language containing sufficient detail to advise the beneficiary of the uses and disclosures permitted or required under applicable law. • Applicant obtains written authorization for all uses and disclosures of protected health information not otherwise permitted under the Privacy Rule. Beneficiaries may authorize disclosure of their protected health information to a third party, such as their employer. Such authorization may NOT be requested for marketing products or services outside the drug card program’s approval. • Applicant ensures that its agents and subcontractors comply with all the requirements of 45 CFR Parts 162 and 164 when performing functions on the Applicant’s behalf. • Applicant complies with the requirements applicable to covered entities to the provisions of 45 CFR Part 160 relating to use of national identifiers. Applicant complies with any applicable standards, implementation specifications, and requirements in the Standards for Electronic Transactions under 45 CFR Parts 160 and 162 subparts I et seq. Application Requirements: — • Indicate your understanding of and agreement to protect protected health information in accordance with the privacy provisions, (stated in Section 3.5.10 of this document) of the drug card program. • Pursuant to the privacy provisions under this initiative: • Describe how your organization will routinely us...
AutoNDA by SimpleDocs

Related to Privacy/HIPAA Transactions

  • Privacy Laws The Dealer Manager and Dealer (each referred to individually in this section as “party”) agree as follows:

  • Privacy Matters (1) For the purposes of this section, “

  • Non-Arm’s Length Transactions Except in respect of transactions between or among the Borrower and/or one or more of its Wholly-Owned Subsidiaries, the Borrower shall not, nor shall it permit any Subsidiary to, enter into any contract, agreement or transaction whatsoever, including for the sale, purchase, lease or other dealing in any property or the provision of any services (other than office and administration services provided in the ordinary course of business), with any Related Party except upon fair and reasonable terms, which terms are not less favourable to the Borrower or its Subsidiaries than it would obtain in an arm’s length transaction and, if applicable, for consideration which equals the fair market value of such property or other than at a fair market rental as regards leased property.

  • HIPAA HMO shall comply with applicable provisions of HIPAA. This includes, but is not limited to, the requirement that the HMO’s MIS system comply with applicable certificate of coverage and data specification and reporting requirements promulgated pursuant to HIPAA. HMO must comply with HIPAA EDI requirements.

  • Insider Transactions There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course of business) or guarantees of indebtedness by the Company or any of its subsidiaries to or for the benefit of any of the officers or directors of the Company, any of its subsidiaries or any of their respective family members, except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus. All transactions by the Company with office holders or control persons of the Company have been duly approved by the board of directors of the Company, or duly appointed committees or officers thereof, if and to the extent required under applicable law.

  • Formation Transactions The Formation Transactions shall have been or shall be consummated substantially concurrently in accordance with the timing set forth in the respective Formation Transaction Documentation.

  • Processing Transactions 2 2.1 Timely Pricing and Orders.................................... 2 2.2

  • Third-Party Information; Privacy or Data Protection Laws Each Party acknowledges that it and members of its Group may presently have and, following the Effective Time, may gain access to or possession of confidential or proprietary information of, or personal information relating to, Third Parties (i) that was received under confidentiality or non-disclosure agreements entered into between such Third Parties, on the one hand, and the other Party or members of such Party’s Group, on the other hand, prior to the Effective Time; or (ii) that, as between the two Parties, was originally collected by the other Party or members of such Party’s Group and that may be subject to and protected by privacy, data protection or other applicable Laws. Each Party agrees that it shall hold, protect and use, and shall cause the members of its Group and its and their respective Representatives to hold, protect and use, in strict confidence the confidential and proprietary information of, or personal information relating to, Third Parties in accordance with privacy, data protection or other applicable Laws and the terms of any agreements that were either entered into before the Effective Time or affirmative commitments or representations that were made before the Effective Time by, between or among the other Party or members of the other Party’s Group, on the one hand, and such Third Parties, on the other hand.

  • Anti-Corruption Matters Since its fiscal year ended in 2015, none of Giga, any of its Subsidiaries or any director, officer or, to the Knowledge of Giga, employee or agent of Giga or any of its Subsidiaries has: (i) used any funds for unlawful contributions, gifts, entertainment, or other unlawful payments relating to an act by any Governmental Authority; (ii) made any unlawful payment to any foreign or domestic government official or employee or to any foreign or domestic political party or campaign or violated any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iii) made any other unlawful payment under any applicable Law relating to anti-corruption, bribery, or similar matters. Since its fiscal year ended in 2015, neither Giga nor any of its Subsidiaries has disclosed to any Governmental Authority that it violated or may have violated any Law relating to anti-corruption, bribery, or similar matters. To the Knowledge of Giga, no Governmental Authority is investigating, examining, or reviewing Giga’s compliance with any applicable provisions of any Law relating to anti-corruption, bribery, or similar matters.

  • Certain Transactions The Warrant Agent, and its officers, directors and employees, may become the owner of, or acquire any interest in, Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder, and, to the extent permitted by applicable law, it or they may engage or be interested in any financial or other transaction with the Company and may act on, or as depositary, trustee or agent for, any committee or body of holders of Warrant Securities or other obligations of the Company as freely as if it were not the Warrant Agent hereunder. Nothing in this Warrant Agreement shall be deemed to prevent the Warrant Agent from acting as trustee under any indenture to which the Company is a party.

Time is Money Join Law Insider Premium to draft better contracts faster.